Enabling CNV Studies from Single Cells Using Whole Genome Amplification and Low Pass Sequencing

A bone marrow-derived progenitor cell population has been identified, which can alter the tumor microenvironment and enhance anti-tumor responses.

Dr. Peter Czabotar of the Walter and Eliza Hall Institute, Australia, discusses his discovery of how a key molecule, Bax, changes its shape to drive cell death.

The PromethION is Oxford Nanopore Technologies' largest sequencing device, capable of delivering many terabases of data, in real time, from a single run. Hear how teams across a broad range of applications, based in labs all over the world — US (UCSF, UCD, JCVI and UCSC), China (GrandOmics and Biomarker) and Europe (KeyGene, Genescope and UMC Utrecht) — are using PromethION in their work.